Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2020, Vol. 40 Issue (11): 110-113    DOI: 10.13523/j.cb.2007043
    
Download: HTML   PDF(308KB) HTML
Export: BibTeX | EndNote (RIS)      
Received: 24 July 2020      Published: 11 December 2020
Cite this article:

. . China Biotechnology, 2020, 40(11): 110-113.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2007043     OR     https://manu60.magtech.com.cn/biotech/Y2020/V40/I11/110

[1]   CLSI. Measurement procedure comparision and bias estimation using patient samples. 3rd ed. CLSI guideline EP9-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2013.
[2]   CLSI. User protocol for evaluation of qualitative test performance. 3rd ed. CLSI guideline EP12-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
[3]   CLSI. Evaluation of precision performance of quantitative measurement methods. 2nd ed. CLSI guideline EP5-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2004.
[4]   CLSI. Protocols for determination of limits of detection and limits of quantitation. CLSI guideline EP17-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2004.
[5]   CLSI. Evaluation of the linearity of quantitative measurement procedures: a statistical approach. CLSI guideline EP6-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2003.
No related articles found!